Eisai and FCNT Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia Nov 30, 2021 09:13 HKT/SGT Read More
Eisai to Present Latest Data on Perampanel and E2730 at the 75th American Epilepsy Society Annual Meeting Nov 30, 2021 08:56 HKT/SGT Read More
European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) for Patients With Certain Types of Endometrial Carcinoma Nov 29, 2021 11:44 HKT/SGT Read More
European Commission Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) as First-Line Treatment for Adult Patients With Advanced Renal Cell Carcinoma Nov 29, 2021 09:15 HKT/SGT Read More
SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health Nov 26, 2021 18:26 HKT/SGT Read More
Inaugural Asia Summit on Global Health successfully explores healthcare landscape Nov 25, 2021 20:00 HKT/SGT Read More
ACT Genomics and Sanomics Merge to Unleash Hong Kong's Global Potential in Healthcare Technology Nov 22, 2021 16:57 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组 Nov 22, 2021 10:42 HKT/SGT Read More
冠科美博(Apollomics)Uproleselan 注射液(APL-106)用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組 Nov 22, 2021 10:41 HKT/SGT Read More
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia Nov 22, 2021 10:40 HKT/SGT Read More